Fatimabatoul Rabaa, PA-C

Fatimabatoul Rabaa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Fatimabatoul Rabaa's NPI, 1457072787, was assigned on September 6, 2022. Fatimabatoul Rabaa holds Texas license PA16518.

Fatimabatoul Rabaa's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Fatimabatoul Rabaa's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Fatimabatoul Rabaa practices. Vendor and product names are available with a free account.

Physician assistant is Fatimabatoul Rabaa's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Fatimabatoul Rabaa is licensed in Texas.

CMS counts 28 Medicare patients who saw Fatimabatoul Rabaa in 2024. 75% of them have high blood pressure, and 61% have cancer. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Fatimabatoul Rabaa's median patient age at 65, with 53% women.

In 2024, Fatimabatoul Rabaa wrote 101 Medicare Part D claims for 40 patients. 68% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Fatimabatoul Rabaa for performance year 2024, reported as part of a group. Fatimabatoul Rabaa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Fatimabatoul Rabaa as offering telehealth.

CMS Open Payments shows 2 general payments to Fatimabatoul Rabaa from 1 drug or device company in 2025. Honoraria make up the largest share, 93% of the total. Exelixis Inc. paid the most, $867.